Frontiers in Biology

, Volume 13, Issue 3, pp 226–234 | Cite as

Mobile blood collection sites and their roles in providing safe and adequate supply: A six-year experience

  • Mostafa Paridar
  • Abbas KhosraviEmail author
  • Mohammad-Ali Jalali-Far
  • Sima Zolfaghari
  • Omid Kiani Ghaleh Sardi
  • Mehdi Sajadi
Research Article



The determination of the role of mobile sites, as compared with fixed sites, in providing safe blood supply will help with the planning of future programs.

Materials and Methods

This retrospective study was carried out at the Khuzestan Blood Transfusion Organization from 2007 to 2012. Samples of the blood collected at mobile sites and fixed sites were compared. Comparisons took into consideration noticeable trends as well as the prevalence of major TTIs including HIV, HBV and HCV.


The total number of blood donations from 2007 to 2012 was 621117 out of which 89590 (14.43%) were collected from mobile sites. The overall blood donation index was estimated at 23.8 per 1000 population. The prevalence of HIV, HBV and HCV in mobile site donations was 5.31, 320.34 and 117.4, and in fixed sites was 5.31, 214.72 and 104.83 per 100000 donations respectively. HBV prevalence in mobile sites was significantly higher than in fixed sites (p = 0.014).


The blood donation index in Khuzestan province is much better when compared with areas of similar socioeconomic status as well as neighboring countries. The allotment of blood units collected by mobile teams is lower than that of national reports. In addition, the prevalence of TTIs in mobile site blood donations was higher than at fixed sites.


fixed sites mobile sites blood donations TTIs Iran 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



This work was financially supported by grant: (91S94) from the Vice- Chancellor for Research Affairs of Ahvaz Jundishapur University of Medical Sciences. This study was carried out at the Khuzestan blood transfusion organization. We acknowledge all the employees of the KHBTO who provided and reported all the data used in this study, particularly Mr Torabi Zadeh Maatoghi, for extracting these data.


  1. Abhishekh B, Usha K (2013). Donor profile and blood safety: comparison between fixed (institute) and mobile site (CAMP) blood collections. International Journal of Current Research and Review, 5(1): 32–35Google Scholar
  2. Adouani B, Alami R, Laouina A, Benahadi A, Boulahdid S, Mokhtari A, Soulaymani A, Abouyoub A, Benajiba M (2013). Hepatitis B in Moroccan blood donors: a decade trend of the HBsAg prevalence in a resources limited country. Transfus Med, 23(6): 432–437CrossRefPubMedGoogle Scholar
  3. Al Shaer L, AbdulRahman M, John T J, AlHashimi A (2012). AbdulRahman M, John TJ, AlHashimi A. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion, 52(11): 2300–2309CrossRefPubMedGoogle Scholar
  4. Belayneh T, Messele G, Abdissa Z, Tegene B (2013). Blood requisition and utilization practice in surgical patients at University of Gondar Hospital, Northwest Ethiopia. Journal of blood transfusion. 2013: 758910CrossRefPubMedPubMedCentralGoogle Scholar
  5. Carey P M, High P M, Schlumpf K S, Johnson B R, Mast A E, Rios J A, Simon T L, Wilkinson S L (2012). Donation return time at fixed and mobile donation sites. Transfusion, 52(1): 127–133CrossRefPubMedGoogle Scholar
  6. Cheraghali A (2012). Overview of blood transfusion system of Iran: 2002–2011. Iran J Public Health, 41(8): 89PubMedPubMedCentralGoogle Scholar
  7. Chiamchanya N (2014). The prevalence of transfusion-transmissible infection in blood donors in Thammasat University Hospital between 2007–2012. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 97(10): 1055–63PubMedGoogle Scholar
  8. Flichman D M, Blejer J L, Livellara B I, Re V E, Bartoli S, Bustos J A, Ansola C P, Hidalgo S, Cerda M E, Levin A E, Huenul A, Riboldi V, Treviño EMC, Salamone H J, Nuñez F A, Fernández R J, Reybaud J F, Campos R H (2014). Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infect Dis, 14(1): 218CrossRefPubMedPubMedCentralGoogle Scholar
  9. Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R, Wang N (2011). Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis, 11(1): 88CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gharehbaghian A (2012). Introduction of a program for voluntary blood donations in Iran (blood transfusion status in Iran). ISBT Sci Ser, 7(1): 183–187CrossRefGoogle Scholar
  11. Hong Y, Huang X, Ling H, Liao H (2012). Prevalence and trend of HIV infection among voluntary blood donors in China since implementation of the Blood Donation Law: a systematic review and metaanalysis. Trop Med Int Health, 17(8): 978–988CrossRefPubMedGoogle Scholar
  12. Iran Ministry of health (2011). Center for disease control. Annual report of HIV in Iran. December of 2011Google Scholar
  13. James A B, Josephson C D, Shaz B H, Schreiber G B, Hillyer C D, Roback J D (2014). The value of area-based analyses of donation patterns for recruitment strategies. Transfusion, 54(12): 3051–3060CrossRefPubMedGoogle Scholar
  14. Kasraian L (2010). Trends in the frequency of blood donors donating blood to be tested for HIV in Shiraz from 2004 to 2006. Transfus Med, 20(2): 127CrossRefGoogle Scholar
  15. Keshvari M, Sharafi H, Alavian S M, Mehrabadi H, Zolfaghari S (2015). Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus Apheresis Sci, 53(1): 38–47CrossRefGoogle Scholar
  16. Khodabandehloo M, Roshani D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2013;18(8): 674Google Scholar
  17. Likatavicius G, Hamers F F, Downs A M, Alix J, Nardone A (2007). Trends in HIV prevalence in blood donations in Europe, 1990–2004. AIDS, 21(8): 1011–1018CrossRefPubMedGoogle Scholar
  18. Lucky T T, Seed C R, Keller A, Lee J, McDonald A, Ismay S, Wand H, Wilson D P (2013). Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010. Transfusion, 53(11): 2751–2762CrossRefPubMedGoogle Scholar
  19. Maghsudlu M, Nasizadeh S (2011). Iranian blood donors’ motivations and their influencing factors. Transfus Med, 21(4): 247–252CrossRefPubMedGoogle Scholar
  20. Maghsudlu M, Nasizadeh S, Abolghasemi H, Ahmadyar S (2009). Blood donation and donor recruitment in Iran from 1998 through 2007: ten years’ experience. Transfusion, 49(11): 2346–2351CrossRefPubMedGoogle Scholar
  21. Meena M, Jindal T, Hazarika A (2011). Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study. Transfusion, 51(1): 198–202CrossRefPubMedGoogle Scholar
  22. Mirrezaie S M, Saber H R, Hajibeigi B, Salekmoghaddam E, Abbasian A, Alavian S M (2014). Impact of HBV vaccination on prevalence of hepatitis B virus infection among volunteer blood donors in Tehran-Iran. Shiraz E Med J, 15(2): e18066CrossRefGoogle Scholar
  23. Mohammadali F, Pourfathollah A A (2014). Changes in Frequency of HBV, HCV, HIV and Syphilis Infections among Blood Donors in Tehran Province 2005–2011. Arch Iran Med, 17(9): 613PubMedGoogle Scholar
  24. Pourfathollah A, Hosseini Divkolaye N, Seighali F (2015). Four decades of National Blood Service in Iran: outreach, prospect and challenges. Transfus Med, 25(3): 138–143CrossRefPubMedGoogle Scholar
  25. Razjou F, Maghsudlu M, Nasizadeh S, Zadsar M (2012). The impact of donor selection on blood safety in Iran. Transfus Apheresis Sci, 47(1): 13–16CrossRefGoogle Scholar
  26. Rose W N, Dayton P J, Raife T J (2011). An analysis of mobile whole blood collection labor efficiency. Transfusion, 51(7pt2): 1609–1612CrossRefPubMedGoogle Scholar
  27. Rudowska E, Basta L, Piwowarska G, Drybańska B, Dylag S (2011). [The epidemiological trends connected with detection of HIV, HCV, HBV and syphilis markers in blood donors in the years 2006–2009]. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego. 30(177): 181–6Google Scholar
  28. Shi L, Wang J, Liu Z, Stevens L, Sadler A, Ness P, Shan H (2014). Blood donor management in China. Transfus Med Hemother, 41(4): 273–282CrossRefPubMedPubMedCentralGoogle Scholar
  29. Singh K, Bhat S, Shastry S (2009). Trend in seroprevalence of Hepatitis B virus infection among blood donors of coastal Karnataka, India. J Infect Dev Ctries, 3(05): 376–379PubMedGoogle Scholar
  30. Song Y, Bian Y, Petzold M, Ung C O L (2014). Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One, 9(4): e94528CrossRefPubMedPubMedCentralGoogle Scholar
  31. Suligoi B, Raimondo M, Regine V, Salfa M C, Camoni L (2010). Epidemiology of human immunodeficiency virus infection in blood donations in Europe and Italy. Blood Transfus, 8(3): 178PubMedPubMedCentralGoogle Scholar
  32. Uzun B, Güngör S, Demirci M (2013). Seroprevalence of transfusion transmissible infections among blood donors in western part of Turkey: A six-year study. Transfus Apheresis Sci, 49(3): 511–515CrossRefGoogle Scholar
  33. Van Veen T, Hunt J A (2015). Tissue engineering red blood cells: a therapeutic. J Tissue Eng Regen Med, 9(7): 760–770CrossRefPubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Mostafa Paridar
    • 1
  • Abbas Khosravi
    • 2
    Email author
  • Mohammad-Ali Jalali-Far
    • 2
  • Sima Zolfaghari
    • 2
  • Omid Kiani Ghaleh Sardi
    • 3
  • Mehdi Sajadi
    • 4
  1. 1.Deputy of Management and Resources DevelopmentMinistry of Health and Medical EducationTehranIran
  2. 2.Transfusion Research CenterHigh Institute for Research and Education in Transfusion MedicineTehranIran
  3. 3.Department of HematologIran University of Medical SciencesTehranIran
  4. 4.Faculty of Allied MedicineBirjand University of Medical SciencesBirjandIran

Personalised recommendations